Uncategorized
Creatd (NASDAQ: CRTD), the parent company of Vocal, today announced its first collaboration in partnership with Plant Camp, a consumer-packaged-goods (“CPG”) company. According to the update, the collaborators have launched their first product, a healthy take on mac and cheese for kids. Plant Camp is the inaugural partner of the company’s corporate venture division, Creatd Partners, spearheaded by Creatd’s president and founder, Justin Maury, and COO Laurie Weisberg. “We have long envisioned DTC (direct-to-consumer) brands as an ideal beneficiary to leverage the power of our proprietary technology,” Maury said in the news release. “Having created successful campaigns with DTC brands such as Cleancult, Lull, and Kettle & Fire, we were able to accelerate Plant Camp’s go-to-market timeline, such that consumers can now place pre-orders through their e-commerce store at https://plantcamp.com.”
To view the full press release, visit https://ibn.fm/VAGgo
About Creatd Inc.
Creatd empowers creators, brands and entrepreneurs through technology and partnership. Its flagship technology, Vocal, is a best-in-class creator platform. For more information about Creatd and its Vocal platform, visit www.Creatd.com and www.Vocal.media.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced that its president and interim CEO Tom Smith will be presenting at the 13th annual LD Micro Main Event on Tuesday, Dec. 15, 2020. Smith’s presentation is scheduled to begin at 1 p.m. ET. Interested parties should visit https://ibn.fm/VA84S to download the company’s presentation and watch the live webcast, as well as https://ibn.fm/cMxIS to view WRAP’s LD Micro proile.
To view the full press release, visit http://ibn.fm/P4oGL
About Wrap Technologies Inc.
Wrap Technologies is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in a number of cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, and Oak Ridge. For information about the company, please visit www.WRAP.com.
NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at http://ibn.fm/WRAP
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
As the short- and long-term effects of continued opioid use have become more apparent, people have started experimenting with safer alternatives. Cannabis and kratom, a tropical evergreen tree in the coffee family, have emerged as promising candidates. Cannabis has long been used as a medicine to treat everything from chronic pain to stress and anxiety. Leaves and leaf extracts from kratom, which is legal in the United States, have been used as a stimulant and sedative, and the natural substance has also been reported to be effective at treating chronic pain.
A federal health agency is now conducting a review of studies into cannabis’s and kratom’s alleged pain-relieving abilities to see if the two could be used to treat chronic pain conditions with reduced side effects. The Agency for Healthcare Research and Quality (“AHRQ”) says that the increase in opioid use, as well as overdoses, underscores the need for safer, plant-based alternatives.
AHRQ, which is part of the U.S. Department of Health and Human Services, is also asking the public to point out any research on the benefits and risks of cannabinoids and kratom. Cannabinoids are chemical compounds produced by the cannabis plant, and they are responsible for its therapeutic and psychoactive effects. The agency stated in a public notice that cannabinoids, specifically THC, may have analgesic properties, but the research is “mixed.”.
Additional cannabinoids such as CBD, CBC and CBG may also have analgesic or anti-inflammatory properties, but they may be less potent than THC, AHRQ says. This isn’t the first time the agency has sought the public’s help in identifying studies on the risks and benefits of using cannabis for pain relief. Back in March 2019, the group announced that it was currently reviewing existing research on alternatives to opioids. AHRQ ultimately said that it didn’t find enough evidence to draw accurate conclusions.
The systematic review will ask four key questions: In adults with chronic pain, what are the benefits of cannabinoids? In adults with chronic pain, what are the harms of cannabinoids? In adults with chronic pain, what are the benefits of kratom or other plant-based substances for the treatment of chronic pain? In adults with chronic pain, what are the harms of kratom or other plant-based substances for chronic pain treatment?
The public will have until Jan. 4, 2021, to submit either published or unpublished research on the benefits and risks of using cannabis or kratom instead of opioids for chronic pain relief.
Aside from the research being done by the feds, several companies are soaring as a result of the legalization of hemp and marijuana. For example, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) was launched in 2012, but it has made great strides in staking its claim as the maker of the best-tasting waster globally. WTER edibles and topicals, all infused with CBD, are also a hit.
NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) are available in the company’s newsroom at http://cnw.fm/WTER
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
- Collection and use of big data have become increasingly important to any company seeking to interact with its stakeholders
- SRAX’s Sequire, an investor intelligence platform, provides its publicly listed corporate client base with insights gleaned from over 1 million strong investor user base
- Sequire allows companies to accurately gather, harness key investor data points, which can help boost their market value and shareholder base
SRAX (NASDAQ: SRAX), a financial technology company focused around unlocking data and insights for publicly traded companies through Sequire, has seen its services gain increased prominence as investors and corporations radically shift the manner in which they interact with one another. Publicly listed companies have progressively turned towards the use of artificial intelligence, machine learning and the collation of big data to improve upon communication and dealings with existing and potential investors. With investors increasingly incorporating new technologies into their processes as they search for an investment edge, corporations have trended towards following suit – however, the task has not come about without its own inherent challenges.
One of the key quandaries faced by corporations is the daunting task of managing vast and ever-changing quantities of data while simultaneously attempting to leverage it as a strategic asset (https://ibn.fm/EIK8A). Launched as a stand-alone platform in early 2020, Sequire, SRAX’s SAAS investor intelligence platform, has sought to address this corporate need by leveraging the over 1 million investors and traders on its platform. Sequire helps harness the digital insights garnered from its active user base in a bid to help its publicly listed corporate clients with their individual investor outreach programs.
Sequire allows its corporate customers to track their shareholders’ selling and buying trends, search and monitor key investors, track outstanding warrants, receive the latest company specific news and media and even create and send out customized shareholder surveys designed to bring forth their stake-holders’ insights and opinions (https://ibn.fm/i2d2n).
The proper use of investor data can have a significant impact on a listed company’s fortunes. In one example, SRAX’s management illustrated the platform’s potential wherein a single corporate subscriber using Sequire witnessed their number of individual shareholders swell from 3,000 to over 360,000 throughout the course of their tenure on the platform (https://ibn.fm/CCakX).
However, the mismanagement of data can impact a company’s potential results. A study carried out by Forbes magazine found that over 70% of active party-data held by companies was incorrect, ambiguous, and/or incomplete (https://ibn.fm/J6Pkw). Situations like these have consequently increased the demand for investor intelligence platforms such as Sequire, which can assist corporations collect and accurately utilize the data and insights gathered from a broad cross-section of the global investor universe.
Over time, big data and artificial intelligence are set to become increasingly significant factors governing the development of the investor relations function – providing issuers with greater insights into their end investors while simultaneously allowing them to personalize their end interactions with the latter group (https://ibn.fm/61zUT). The recognition of these upcoming changes has underpinned the ongoing development of the Sequire platform, ideally situating it to benefit from the ongoing radical transformation of the global investor relations industry.
For more information, visit the company’s website at www.SRAX.com
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
NEW YORK, Dec. 14, 2020 — Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.
Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, December 17 th with the first live webcast at 9:30 AM ET.
REGISTER NOW AT: https://bit.ly/3oTRSRH
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.
Agenda and presenting companies:
To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com .
About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com
- Report notes that NETE is showing surprising business strength despite lockdowns persisting in New York, California
- Once restrictions are eased, company should rebound sharply
- Agreement between NETE, Mullen outlines stock-for-stock reverse merger in which Mullen stockholders will receive outstanding stock in post-merger company
With its previously announced definitive agreement with Mullen Technologies, a Southern California-based electric vehicle company, still in process, Net Element (NASDAQ: NETE) is valued only on its card-processing business. With 45% of its customers in the restaurant business — a space that has been deeply impacted by COVID-19 — Net Element revenues actually improved sequentially, reported a recent Zacks Small-Cap Research report (https://ibn.fm/vLGgP).
“Net Element is showing surprising business strength despite lockdowns persisting in New York, where it has numerous customers in the restaurant business,” the report noted. “Management claims the US economy is running on the sunbelt, and business could be gangbusters if shut-down states would just open up.”
The report went on to note that, while opening back up is impossible to predict, when it does, “we expect Net Element business to rebound sharply. With 45% of its customers in the restaurant business, this is the most important factor to improvements at Net Element’s card processing volumes. Another meaningful factor is tourism, especially in Florida, which is impacted by people’s perception of the safety of travel as well as the quarantine requirements in various states.”
In spite of the global pandemic, NETE Q3 2021 revenues came in at $16.7 million, up from the $13.7 million reported in Q2 2020 and down only slightly from numbers reported a year ago. In addition, Zacks noted that NETE’s North American sales were up 1% year over year.
With its eyes on the upcoming merger with Mullen, which Zacks expects to close in Q1 2021, Net Element plans to divest its payment-processing business before year-end, according to the report. Currently the global financial technology and value-added solutions group supports electronic payments acceptance in an omni-channel environment that includes point-of-sale, e-commerce and mobile devices. NETE operates a payments-as-a-service transactional model targeting small to medium businesses in the United States and other emerging markets.
Mullen Technologies is also moving forward on the merger journey and its plans to make and sell electric vehicles (EVs). Earlier this year, the company began construction of a pilot manufacturing facility and started taking pre-orders on its $55,000 MX-05 fully electric SUV model. The pilot facility will be used to assemble up to 1,000 MX-05 vehicles per year, with other models added as announced. The facility supports a process that includes general and battery assembly as well as R&D.
“We are excited to begin the build-out of our pilot facility and pre-sales of our MX-05 SUV in October,” said Mullen Technologies chairman and CEO David Michery (https://ibn.fm/vLFhR). “We plan on completing the build-out by April 2021 and to begin assembly of certification prototypes by July 2021. These vehicles will be used for homologation, which is expected to take 16 months and be completed by May of 2022, at which time we expect to begin delivering the first vehicles to the public.”
The agreement between NETE and Mullen outlines a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is pending shareholder vote and regulatory approval.
For more information, visit the company’s website at www.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.GreenCarStocks.com
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com
Green Car Stocks is part of the InvestorBrandNetwork.
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, today announced its entry into a three-year supply agreement with The Chemours Company (NYSE: CC) to acquire a minimum of 2,500 tons per year of natural monazite sands, one of the highest-grade rare earth element (“REE”) minerals in the world. According to the update, Energy Fuels expects to process this monazite at its 100%-owned White Mesa Mill starting in Q1-2021, recover the contained uranium, and produce a marketable mixed REE carbonate, representing an extremely important step toward re-establishing a fully-integrated U.S. REE supply chain. “With our announcement today, southeast Utah is fast becoming America’s clean energy and critical minerals hub,” said Mark S. Chalmers, president and CEO of Energy Fuels. “Our goal is to domestically produce the raw materials needed for clean energy and advanced technologies, while creating green jobs in an economically challenged part of the country. Currently, the U.S. imports nearly all of our rare earth, uranium and vanadium requirements, despite having ample supplies here in the U.S. Importantly, in the United States we are highly regulated and operate to the highest standards, which means we produce these minerals more responsibly than many of the countries from which we currently import. Our agreement with Chemours may be the beginning of a real success story, not only for Energy Fuels, but also for local communities, Native Americans, conservation groups, the State of Utah, and the U.S. as a whole.”
To view the full press release, visit http://ibn.fm/Ax25T
About Energy Fuels Inc.
Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.MiningNewsWire.com
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com
MiningNewsWire is part of the InvestorBrandNetwork.
Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, today announced the close of its acquisition of 100% of the shares in Adelia Therapeutics Inc. for up to CA$20,161,575 (approximately US$15.75 million). “We are thrilled to join forces with Adelia. We see this acquisition as potentially advancing Cybin’s ability to innovate our psychedelic drug development program and diversify beyond major depressive disorder,” said Cybin CEO Doug Drysdale. “Adelia’s focuses on novel delivery methods and innovative therapies may contribute to our goal of therapies with faster onset of action, smoother pharmacokinetic profiles, shorter treatment periods, and reduced side effects. Adelia’s expertise across multiple molecules and multiple indications, could potentially give Cybin the ability to address gaps across a larger domain.”
To view the full press release, visit https://ibn.fm/GHbm6
About Cybin Inc.
Cybin is a life sciences company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions. Cybin is developing technologies and delivery systems, aiming to improve bioavailability, to potentially achieve the desired medicinal effects of psychedelics at low dosage levels. The new delivery systems are expected to be studied through clinical trials to confirm safety and efficacy. For more information, visit the company’s website at www.Cybin.com.
NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at http://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
There are some aspects of the coronavirus that scientists do not know enough about, seeing as it’s a completely new virus that attacks the lungs as well as other parts of the body. However, the strides that have been made in the last few months with regard to research — and now a vaccine — are a clear indication that researchers are working hard to discover as much as they can.
Recently, University of Vermont collaborators and biomedical engineers from Boston University discovered have studied how the coronavirus causes silent hypoxia in patients. Hypoxia is a condition that causes abnormally low oxygen levels in the body, which can cause irreparable damage to vital organs, especially if not detected early.
Many severe coronavirus patients show no symptoms of shortness of breath symptoms or difficulty breathing, despite experiencing very low oxygen levels. Scientists believe that the COVID-19 infection first damages a patient’s lungs, making it hard for them to function normally. This causes the lung tissue to lose oxygen and stop working, which means that the patient’s bloodstream is no longer being supplied with oxygen, causing silent hypoxia.
Bela Suki, an author of the study who is also a Boston College professor of materials science, engineering and biomedical engineering, explained that some patients with coronavirus displayed almost no signs of abnormalities, despite the fact that, when tested, their blood oxygen levels were termed “incompatible with life.”
Through the use of computer modeling, biomedical engineers from Boston University were able to find out what led to silent hypoxia. The researchers tested three different scenarios to help explain why and how the lungs stopped infusing oxygen to a patient’s bloodstream. The lead author of the study, biomedical engineer Jacob Herrmann, discovered that a combination of biological mechanisms, which may take place simultaneously in the lungs of patients with the coronavirus infection, may be the cause of silent hypoxia. This research was reported in the “Nature Communications” journal.
Suki, Herrmann and the team of researchers also discovered that for the levels of oxygen in the blood to decrease to the levels seen in patients with the coronavirus infection, the flow of blood would have to be significantly higher than normal in parts of the lungs where oxygen was no longer being infused. This, they said, could contribute to low oxygen levels throughout the patient’s body.
Additionally, the researchers used computer modeling of the lungs to look into how blood clotting may affect the flow of blood to different parts of the lungs. They discovered that while this may encourage silent hypoxia, blood clotting by itself would not be enough to cause a decline in oxygen levels to the levels recorded in patients with the COVID-19 infection.
The researchers also discovered that a mismatched air-to-blood ratio, which occurs in other respiratory ailments, may also be a contributor to the silent and severe hypoxia that has been detected in coronavirus patients.
The researchers’ findings suggest that all three factors combined may be the culprit responsible for the severe low-oxygen levels observed in some coronavirus patients. Suki explained that understanding these underlying mechanisms better and knowing that these combinations are different for different patients would go a long way in helping clinicians decide on the proper form of treatment that a patient would require.
COVID-19 isn’t the only disease giving biomedical firms sleepless nights. AzurRx BioPharma Inc. (NASDAQ: AZRX) has set its sights on developing treatments for diseases that affect the gastrointestinal system. The company’s advanced stage clinical trials are promising to bring to market novel therapies.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced the successful launch of its first “Film Bubble” for a major motion picture that is scheduled to commence filming in January 2021. The film name and starring actors will remain confidential until filming commencement. The launch is the result of a partnership agreement with Draganfly Inc. (CSE: DFLY), which provides Safe Set Solutions for the global film and TV production industry leveraging technology that uses symptom pre-screening, elevated body temperature measurement, and social distancing digital display to help ensure that everybody on the set is safe. “The addition of Draganfly’s Safe Set Solutions to our Venue Bubble Platform creates an instant and powerful Film Bubble solution for an industry that has suffered catastrophic losses in 2020 and can’t afford to stay shut down for a minute longer,” said Loop Insights CEO Rob Anson. “We are extremely proud to have jointly delivered a solution to the film industry that will allow them to safely get their crews, actors, and supporting infrastructure back to work and generating prosperity, the ripple effects of which reverberate around the world.”
To view the full press release, visit http://ibn.fm/ZXsb5
About Loop Insights Inc.
Loop Insights is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network. For more information, visit the company’s website at www.LoopInsights.ai.
NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at http://ibn.fm/RACMF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
NEW YORK, Dec. 11, 2020 — NetworkNewsAudio – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) announces the availability of a broadcast titled, “National Brands Vie for CBD Dominance.”
To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast
To view the full editorial, please visit: https://nnw.fm/WYoJD
One study reported that every dollar spent on email marketing in the CBD industry resulted in almost $40 in revenue. And research by the Brightfield Group shows that roughly one-third of the CBD consumers surveyed indicated they are planning to buy from online retailers rather than in-store during the pandemic, while nearly 50% say they will stock up on supplies if they believe there is going to be a shortage.
The industry seems primed for a leading company to offer a comprehensive line of CBD-infused and topical products — and emerge as a trusted brand. Who better to step into the spotlight than an innovative company that has already firmly established its ability to quickly identify and deliver on consumer needs and market opportunities? Already a well-respected national beverage brand, The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) is committed to building a similar reputation in the CBD sector.
About The Alkaline Water Company
Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp, powder packs, oil tinctures, capsules and gummies. To learn more about the company, visit www.A88CBD.com and www.TheAlkalineWaterCo.com .
NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://nnw.fm/WTER
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness.
NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through its software-as-a-service (“SaaS”) platform, Sequire, today announced that it will host the 13th Annual LD Micro Main Event, a prominent 2-day virtual investor conference, via its Sequire Virtual Events platform. The event is slated to take place on December 14 – 15, 2020, and feature close to 250 companies presenting in a brand-new format, along with engaging celebrity keynotes delivered by Shaquille O’Neal and Brock Pierce. Interested parties should visit https://ibn.fm/beCTN to register for the LD Micro Main Event. “We are excited to bring together one of the largest communities of micro-cap investors to hear from amazing companies,” said Christopher Miglino, founder and CEO of SRAX. “The LD Micro conference has a long history of driving awareness for companies and is just one of the many benefits that the Sequire platform brings to the table when helping public companies.”
To view the full press release, visit http://ibn.fm/xt4rx
About SRAX Inc.
SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com and MySequire.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Ever heard of chronic rhinitis? No? Well, it’s a condition that results in the inflammation of the inner lining of your nose. It can last for more than a month, and statistics show that 77 million individuals in America have the disease. Chronic rhinitis is not acute rhinitis, which only lasts several days.
There are two types of chronic rhinitis: the non-allergic and allergic types. An estimated 19 million individuals in America suffer from the less common non-allergic type while the remaining 58 million have the allergic type, making the latter very common. We discuss both types below.
Non-allergic chronic rhinitis
This type occurs mostly due to various triggers that exist in the environment. Its symptoms present differently in different people and are present year round. Some of these triggers are found in medications, other come from diseases and the environment. These triggers may be mechanical.
There are some medication classifications that are known to cause non-allergic chronic rhinitis. These include birth control pills, NSAIDs such as aspirin, antidepressants, illegal drugs such as cocaine and decongestant drugs that are used for more than three days.
Irritants in the environment
These include latex, detergents, metal salts, exhaust fumes from cars, perfume and tobacco smoke.
Ailments
Chronic sinusitis, gastroesophageal reflux disease and asthma can lead to non-allergic rhinitis.
Apart from the above triggers, extremely hot and spicy foods as well as hormonal changes can also cause non-allergic rhinitis.
Allergic chronic rhinitis
This usually occurs when an individual is exposed to an allergen; it is also often referred to as hay fever. Its causes may include mold, pollen, animal dander, dust and cold.
Both types of chronic rhinitis share the following symptoms:
- Coughing
- Frequent sneezing
- Post-nasal drip
- Congestion of the nose
- A running nose
- Headaches
Chronic rhinitis can be treated in several ways. It should be noted that treatment is the most effective when combined with a lifestyle change. Possible treatments include:
Surgery
If a deviated septum is the cause of your chronic rhinitis, your doctor may recommend surgery. Despite being effective, it is used as a last resort after all other treatment options have been unsuccessful.
Changing your lifestyle
This is mainly done by avoiding anything that may trigger your rhinitis. You can incorporate an air purifier into your home, bathe your pets more often and dust your house frequently.
Medication
Possible medications include antihistamines, which essentially stop the development of rhinitis symptoms such as sneezing and a runny nose. Doctors may also prescribe nasal decongestants, which usually come in form of nasal drops to help alleviate nasal congestion.
Many biomedical firms are hard at work finding solutions to some of the most difficult conditions that people grapple with. For instance, Processa Pharmaceuticals Inc. (NASDAQ: PCSA) specializes in developing drugs for orphan diseases as well as other unmet medical needs.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
The world is slowly working towards fully electrifying its roads, and Europe is leading the charge. Although the continent is behind China in terms of global market share, several European countries have announced plans to ban the sale of new internal combustion engine (“ICE”) vehicles over the next few decades. This year alone, car makers in Europe have sold more than 500,000 battery-powered electric cars, despite the coronavirus pandemic and an historic economic crisis.
According to data collated by Schmidt Automotive Research, more than 1 million plug-in cars, including hybrids, were sold in the UK as well as Europe’s 17 largest markets. Compared to the 354,000 electric cars sold across the entire region last year, this is a significant increase. It can be attributed to stricter emission rules and increased consumer interest, which have prompted vehicle manufacturers to invest in the development of EVs with better range.
The UK has set the ban on new ICE vehicles to 2030; Norway wants all passenger vehicles, urban buses and light commercial vehicles to have zero-emissions in less than five years; and the Netherlands is aiming for all passenger automobiles sold starting from 2030 to be zero emission. Other EU countries, including Iceland, Denmark, Ireland, Slovenia, and Sweden, have also promised to halt the sale of new fossil-fuel passenger cars in a maximum of 10 years.
These stricter CO2 fleet emission targets have pushed EV makers to invest in developing EVs that meet the emission standards, lest they are penalized by their respective governments. Additionally, government-provided fiscal incentives have allowed drivers who couldn’t have afforded the initial purchase price to switch to zero-emission electric vehicles.
However, the continent is still a long way from widespread adoption. Electric vehicles make up only 5.5% of the market share in the UK, and none of the most popular cars in the country this year have been electric. Conventional combustion-engined vehicles are still cheaper to manufacture and more profitable than EVs; they made up most of the 13 million vehicles sold in the entire region this year.
To boost EV adoption, governments will have to offer incentives to make the vehicles more affordable to the everyday driver. Electric vehicles are quite expensive to manufacture, and most of these costs are passed on to the consumer. Fortunately, research by investment bank UBS found that by 2024, automakers would be able to produce an EV as cheaply as they would a conventional car. In the meantime, governments will have to offset the costs to encourage EV adoption.
Back in the U.S., the EV industry is evolving rapidly. For instance, Net Element (NASDAQ: NETE), a player in the global fintech space, revealed early in August that it was set to merge with an electric vehicle manufacturer called Mullen Technologies, Inc.
NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.GreenCarStocks.com
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com
Green Car Stocks is part of the InvestorBrandNetwork.
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of critical minerals in the United States, on Thursday announced that its president and CEO Mark S. Chalmers will be presenting live at the 13th Annual LD Micro Main Event investor conference. The event will take place on Dec. 14 – 15, 2020, exclusively on the Sequire Virtual Events platform, and feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts. Chalmers’ presentation is scheduled to begin at 11:40 a.m. EST on Dec. 14, 2020. He will provide an update on Energy Fuels’ various critical mineral initiatives, with particular emphasis on the company’s progress on rare earth elements. Interested parties should visit https://ibn.fm/beCTN to register for the LD Micro Main Event.
To view the full press release, visit http://ibn.fm/hEwzW
About Energy Fuels Inc.
Energy Fuels is the largest uranium producer in the U.S. and holds more production capacity and uranium resources than any other U.S. producer. The company also produces vanadium. Headquartered in Colorado, Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch ISR Facility in Wyoming, and the Alta Mesa ISR Facility in Texas. The producing White Mesa Mill is the only conventional uranium mill in the U.S. and has a licensed capacity of 8 million pounds of U3O8 per year. Nichols Ranch is in production and has a licensed capacity of 2 million pounds of U3O8 per year. Alta Mesa is currently on standby. Energy Fuels also owns several licensed and developed uranium and vanadium mines on standby and other projects in development. For more information, visit the company’s website at www.EnergyFuels.com.
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.MiningNewsWire.com
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com
MiningNewsWire is part of the InvestorBrandNetwork.
AzurRx BioPharma (NASDAQ: AZRX) is focused on the development of its lead drug candidate, MS1819, for exocrine pancreatic insufficiency (“EPI”) in patients suffering from cystic fibrosis (“CF”) and chronic pancreatitis (“CP”). While CF is a relatively rare genetic disease, innovative and effective therapies are needed. CF is a dangerous condition that affects multiple body functions and organs, putting patients at risk of developing severe life-threatening illnesses. Technological advances have greatly increased the life span for CF patients. While children with CF rarely made it to elementary school age in the 1950s, the median age of survival for a CF patient is now around 47 years, with many patients living into their 60s (https://ibn.fm/RQcG4). A recent article discusses AZRX’s positioning amid the work in targeted treatments. It reads, “Due to the efforts of companies such as AzurRx BioPharma, the life span and quality of life of CF patients could be further improved. AzurRx’s lead product is MS1819, a recombinant lipase that could potentially change the treatment of exocrine pancreatic insufficiency in CF and CP patients.”
To view the full article, visit: https://ibn.fm/8V7rO
About AzurRx BioPharma Inc.
AzurRx BioPharma is a biopharmaceutical company specializing in the research and development of non-systemic biologics for gastrointestinal disorders. The company is focused on the development of its lead drug candidate, MS1819. AzurRx is currently conducting two Phase 2 clinical trials of MS1819: the OPTION 2 monotherapy trial and the combination therapy trial consisting of MS1819 in conjunction with porcine-derived pancreatic enzyme replacement therapy, the current standard of care. The company is headquartered in Delray Beach, Florida, with clinical operations in Hayward, California. For more information, visit the company’s website at www.AzurRx.com.
NOTE TO INVESTORS: The latest news and updates relating to AZRX are available in the company’s newsroom at http://ibn.fm/AZRX
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
- Loop Insights is aiming to disrupt multiple global markets with its proprietary technologies, including Fobi, SmarTap, Uklipz and the Loop cloud
- Loop successfully deployed the world’s first complete, end-to-end “venue bubble” solution, protecting over 500 NCAA players and staff at the 2020 Gulf Coast Showcase
- Loop Insights’ automated venue tracing service provides real-time notifications of potential COVID-19 exposure and can be used for alerting users during natural disasters or amber alerts
- Loop has established partnerships with a trio of medical testing companies, enabling it to provide a complete end-to-end integrated COVID-19 management platform that includes rapid testing, integrated lab results and venue tracing
- The global IoT market is estimated to reach $561 billion by 2022, positioning the company for significant growth opportunities in the sector
- Loop Insights is also positioned to influence several other global markets during the forecast period, including brick and mortar retail, sports and entertainment, telecom partnerships, casino gaming and cannabis
Loop Insights (TSX.V: MTRX) (OTCQB: RACMF) is an innovative technology company leveraging Internet of Things (“IoT”) technologies to deliver contactless solutions, including its venue management platform, personalized engagement services and AI-driven insights.
The company was founded on June 12, 2019, and is headquartered in Vancouver, Canada. Loop is currently offering its solutions to major players in the telecom, sports, casino gaming, hospitality, entertainment and retail industries across Canada, the United States, South America, the UK, Australia, Indonesia and Japan.
Scaled and Fully Managed Services
Loop Insights has integrated both its Fobi and SmarTap devices with its proprietary cloud to provide end-to-end services for the retail, travel, entertainment and hospitality industries.
Loop’s Automated Venue Management Platform
Loop’s venue management platform is a fully managed contactless check-in platform that securely aggregates venue and visitor information in order to generate real-time feedback to both venue hosts and consumers. Loop’s venue management platform can be applied to venue tracing for COVID-19 or used in traditional environments for applications in ticketing, retail and hospitality.
Loop’s COVID-19 Venue Tracing Solution
Loop Insights is committed to leveraging its solutions for COVID-19 management, allowing for easier tracing, testing and data collection.
Loop Insights has adapted its existing technology to create a venue management platform designed specifically for tracing the COVID-19 pandemic. The company’s complete end-to-end COVID-19 management platform provides a means for venues and event hosts to manage attendees and instantly trace and notify potential at-risk visitors.
Loop Insights has partnered with a number of medical testing companies including iSTOC and Empower Clinics to provide rapid testing options wherever its COVID-19 venue management system is deployed.
Loop Insights signed a referral and partnership agreement with Finland’s iSTOC Ltd. in November 2020, providing the company COVID-19 testing and integrated lab capabilities in Europe. The partnership allows Loop to provide FDA and HIPAA-compliant tracing and testing that can be deployed by any health care organization, NGO or government worldwide. “Our partnership with iSTOC positions us as a true global leader regarding complete COVID-19 management solutions,” Loop Insights CEO Rob Anson explained.
Through its partnership with Summit Services Inc., Loop Insights deployed the first-ever COVID-19 venue bubble solution in a live environment at the Gulf Coast Showcase in Fort Myers, Florida, and #VegasBubble in Las Vegas. The venue bubble was deployed to test, trace and notify over 500 NCAA players, coaches and staff that attended the tournament.
Loop’s Personalized Engagement Platform
Loop Insights’ personalized engagement platform leverages the power of the company’s technology to provide retail operators with an automated marketing platform focused on delivering the right marketing to the right customers to optimize retail engagement.
By leveraging the power of the Wallet pass functionality found on all Android and iOS devices, Loop establishes a direct line of communication with consumers, allowing merchants to provide an AI-personalized marketing experience designed to drive spending and encourage brand loyalty through rewards and other promotions.
Like the digital credit cards or boarding passes that use Wallet pass technology, Loop Insights’ engagement platform provides a seamless user experience without the need to download an additional application. Consumers receive automated promotions and discounts that can be personalized based on user data.
Loop’s Real-Time Insights Platform
By aggregating retail information about consumers and their preferences, Loop’s Insights platform takes the guesswork out of decision making for retailers. Loop’s Insights platform aggregates retail performance data, recording 100% of each transaction before delivering insights and analytics regarding macro and micro buying trends, consumer behavior and optimization opportunities.
As part of its Insights offering, Loop provides AI-based forecasting, modeling and inventory management services to retailers with the ability to integrate third-party data services such as foot traffic and weather.
Loop Insights Devices and Technologies
Loop Insights has developed a line of simple, yet powerful technologies designed to transform industries through the power of IoT technologies and artificial intelligence. The company offers fully automated plug-and-play platforms that can seamlessly integrate and enhance clients’ existing operational infrastructure. The company’s devices are designed to work together seamlessly on top of its enterprise-level cloud infrastructure, providing clients in the retail, entertainment and hospitality industries with the ability to easily optimize their operations.
Fobi
Fobi is an IoT device designed to seamlessly integrate into any existing point of sale or customer management infrastructure. It collects 100% of transactional data and then connects this data to other data points, enabling optimization through AI and data-driven insights.
Loop Insights’ cloud-based AI is designed to aggregate an organization’s data, optimizing the information so it is actionable and easy to use. The Fobi device is hardware agnostic and seamlessly connects with existing points of sale or customer relationship management infrastructure, physically or digitally.
By aggregating an organization’s entire dataset, Fobi is able to merge transactional and behavioral data with customer data to create 360-degree customer profiles, enabling highly-personalized, omnichannel marketing strategies across a number of platforms including email, SMS, paper receipts and the company’s proprietary Wallet pass technology. Loop’s data aggregation service is supported by Amazon Web Services, providing clients with the digital infrastructure and security necessary to protect their data.
SmarTap
SmarTap is a Near Field Communication (“NFC”) device that enables consumers to “tap” to check-in to locations using their smartphone’s NFC compatibility, enabling contactless customer engagement through the use of Wallet pass technology. By leveraging the functionality of the Wallet pass technology found on Android and iOS devices, Loop is able to drive engagement and provide personalized, data-driven insights without the need for an additional application.
Loop’s SmarTap device can connect to the Loop cloud via LTE or Wi-Fi, allowing retailers to securely transfer encrypted data from wherever their businesses operates.
Loop Cloud
The Loop Cloud brings together datapoints from its Fobi and SmarTap devices to create a unified database for the company and its clients. Instead of individual tills and stores generating their own unique datasets, Loop Insights aggregates data together from a number of sources, creating a complete picture of a client’s retail environment.
By hosting this database in the cloud, Loop Insights provides its clients with more accessible and actionable data that can be accessed from anywhere. Additionally, the Loop cloud allows for real-time monitoring, and its API can be directly integrated into existing PoS systems.
When paired with Loop’s Fobi and SmarTap devices, the Loop Cloud allows for businesses to transform their edge-based legacy systems into a unified database that can be accessed from anywhere.
Uklipz
Expected to launch in January 2021, Loop Insights’ latest product offering, Uklipz, is a next-generation platform that enables consumers to create verified video reviews that can be purchased, analyzed and leveraged by brands to drive engagement and sales.
The addition of Uklipz marks an important milestone for the company, because it further strengthens its product portfolio by providing a reliable solution in the massive but problematic consumer review industry, as Anson explained in a November 2020 news release (https://ibn.fm/YpNlR). He added that the company expects this platform to become a very valuable asset and a significant source of revenue in 2021.
Market Outlook
Loop Insights’ integrated technology solutions and its recent advances in providing end-to-end COVID-19 solutions position the company for significant growth opportunities in the expanding IoT market. According to MarketsandMarkets research, the global IoT sector is expected to reach $561 billion by 2022, up from $180.6 billion in 2017. This market growth can be attributed to an increase in cloud platform adoption and a reduction of costs (https://ibn.fm/1BIPB) which Loop is driving through its engagement and insights platforms.
According to Loop Insights’ August 2020 investor presentation, its innovative solutions open the door to multiple opportunities in additional sectors, including but not limited to:
- Brick and mortar retail – an estimated value of $31,880 billion by 2023 (Mordor Research)
- Sports and entertainment – an estimated value of $614.1 billion by 2022 (The Business Research Company)
- Telecom partnerships – an estimated value of $3,435.2 billion by 2022 (The Business Research Company)
- Casino gaming – an estimated value of $565.4 billion by 2022 (Research and Markets)
- Cannabis – an estimated value of $66.3 billion by 2025 (Grandview Research Inc.)
Management Team
Rob Anson is the Chief Executive Officer and Chairman of Loop Insights. He has also served, since October 2017, as the Chief Executive Officer and Founder of Fobisuite Technologies Inc., a private British Columbia technology company. In a prior role, Anson was the Founder and Chief Executive Officer of One Team Media, a private Vancouver-based media company with digital and television production assets.
Abbey Abdiye is Chief Financial Officer of Loop Insights. He is a Chartered Professional Accountant (“CPA”) who has served as Chief Financial Officer for a range of public companies throughout his extensive career. Before obtaining his CPA, he received a Bachelor of Business Administration from Simon Fraser University and completed his Co-Op Education Certificate.
Gavin Lee is the company’s Chief Operating Officer. He has over 20 years of experience with global consumer products, with expertise in building top-performing sales teams, brand management, operational excellence and consumer insights. Lee has a strong business understanding and a background in improving salesforce effectiveness. His experience ranges from small entrepreneurial brands to multi-million-dollar global leaders in a variety of marketing segments.
Casey Matson-DeKay is Chief Technology Officer of Loop Insights. He previously held the same position at Fobisuite Technologies, from January 2017 until January 2018. Matson-DeKay has been a developer and information technology consultant for various enterprises. He has been involved with the core technologies utilized by Loop Insights for nearly a decade.
For more information, visit the company’s website at www.LoopInsights.ai.
NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at https://ibn.fm/RACMF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced several corporate updates including the launch of a multilingual platform. The move will support Canada-wide opportunities with national brands, and the release of Loop’s multilingual capabilities for its digital wallet and venue management platform are essential to anticipated national rollouts of each of its platforms. According to the update, supported languages include English, French and Spanish. “We have now commenced significant discussions surrounding travel bubble opportunities with some of North America’s largest airlines, resort operators, venues, and hospitality groups globally,” Loop CEO Rob Anson said of one of its solutions the company intends to expand in the near future. “We anticipate this new revenue stream may be significant for the company as we progress these opportunities in 2021.”
To view the full press release, visit https://ibn.fm/qXi52
About Loop Insights Inc.
Loop Insights is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network. For more information, visit the company’s website at www.LoopInsights.ai.
NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at http://ibn.fm/RACMF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced that its bid and was selected by the United Kingdom Ministry of Defence into their Defence and Security Accelerator (“DASA”) competition for “Advancing Less Lethal Weapons.” “We are honored to be selected by DASA to explore and pursue further remote restraint solutions,” said Tom Smith, president and interim CEO at WRAP. “We believe this selection reflects the value of our technology as well as the confidence in WRAP as a leader in the law enforcement technology space. It further validates the investment we have made in our skilled engineering team.”
To view the full press release, visit https://ibn.fm/gEXZZ
About About Wrap Technologies Inc.
Wrap Technologies is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in a number of cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, and Oak Ridge. For information about the company, please visit www.WRAP.com.
NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at http://ibn.fm/WRTC
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has been granted a patent by the Korean Intellectual Property Office (“KIPO”) for one of its treatments for depression. VistaGen received notification that KIPO has issued a decision to grant Patent Application No. 10-2015-7020176. The patent relates to VistaGen’s PH10, an investigational neuroactive nasal spray designed to have rapid-onset therapeutic potential in a variety of neuropsychiatric indications involving depression; the patent will not expire earlier than 2034. VistaGen is currently preparing for Phase 2B clinical development of PH10 as a potential stand-alone, rapid-onset treatment for major depressive disorder (“MDD”). “The Republic of Korea is an important pharmaceutical market,” said VistaGen CEO Shawn K. Singh in the press release. “With counterpart patents already issued in the U.S., Greater China , Europe and Japan, this patent enhances our patent protection for PH10 and is a key component of our global commercial protection strategy for PH10.
To view the full press release, visit: https://ibn.fm/RmBaj
About VistaGen Therapeutics Inc.
VistaGen is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated potential mechanism of action, has been well tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets. For more information about the company, please visit www.Vistagen.com.
NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at http://ibn.fm/VTGN
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Trxade Group (NASDAQ: MEDS), through its telehealth subsidiary Bonum Health, has signed a strategic agreement with KPH Healthcare Services (“KPH”), a leading pharmaceutical and healthcare services provider, to provide affordable telemedicine services to two KPH divisions. Trxade, an integrated drug procurement, delivery and healthcare platform, will work through Bonum to serve the patients of approximately 100 Kinney Drug retail pharmacies in New York and Vermont and the more than two million Rx discount card members of Kinney’s sister company, ProAct Inc. Bonum Health provides a mobile, B2C clinical technology platform and telehealth solution that enables virtual medical and provider services at significantly discounted prices. “We are thrilled to have established this partnership with the KPH team, whose deep-rooted commitment to their patients and communities’ dates back to 1903,” said Bonum Health president Ashton Maaraba in the press release. “Our team of medical providers are ready to work in collaboration with Kinney Drugs and ProAct Pharmacists to deliver affordable care to their patient community. With nearly 26 million uninsured or under-insured people in the U.S., partnerships such as these will help narrow gaps and reduce barriers to affordable, accessible care for all.”
To view the full press release, visit https://ibn.fm/pdlVF
About Trxade Group Inc.
Headquartered in Tampa, Florida, Trxade Group is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; (1) the Trxade B2B trading platform with around 11,800 registered pharmacies; (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division; and (3) the Bonum Health platform offering affordable telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
NetworkNewsWire Editorial Coverage via CBDWire: CBD is now legal in all 50 states, and on election day this year, four states voted to legalize the recreational use of cannabis, bringing the total of states allowing recreational cannabis use to 15. This growing acceptance has fueled an influx of new CBD-infused products and brands, leading a Lido Consulting report to note that the total addressable cannabis market (TAM) could potentially hit $1 trillion in global economic impact by 2027. Savvy companies recognize the bright promise of this burgeoning industry and are focused on taking advantage of the massive opportunity. Leading the pack is The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) (Profile), which entered the CBD space with the launch of its A88CBD(TM) brand. Alkaline Water, which already had a nationally recognized line of premium bottled water and flavor-infused water, now offers a full line of CBD-infused and topical products. Others strengthening their positions in the space include Tilray Inc. (NASDAQ: TLRY), which through its wholly owned subsidiary High Park, has a portfolio of “Cannabis 2.0” brands and products. In addition, in a joint venture with Tilray, Anheuser-Busch InBev SA (NYSE: BUD) has announced plans to commercialize non-alcohol, CBD-infused beverages in Canada. And just last month, Aphria Inc. (NASDAQ: APHA) (TSX: APHA) announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio. Curaleaf Holdings Inc. (OTC: CURLF) (CSE: CURA) recently launched its Select Nano Gummies in California and its line of Select Elite Live cartridges in Nevada.
- Projected trillion-dollar market presents compelling opportunity for companies prepared in the space.
- With already-established high standards in place, WTER guarantees that its A88CBD products are unmatched.
- The company just added five category-leading items to its A88CBD line, the perfect complement to its existing product lineup.
A Compelling Opportunity
In its report, Lido Consulting noted the following: “Pause to consider . . . a $1 trillion market in eight years while currently there is not a single company in the space that generates anywhere close to $500 million in revenue. That fragmentation, and the wholly unique phenomenon that a black market with an existing — and massive — consumer and patient base is transitioning to a regulated market, is what makes cannabis such a compelling opportunity.”
The already-high demand has only increased in the past year, with the COVID-19 epidemic sparling stronger online sales. In fact, a recent ASD Market Week article reported that every dollar spent on email marketing in the CBD industry brought in in almost $40 in revenue. That aligns with Brightfield Group research indicating that roughly one-third of CBD consumers surveyed plan to buy from online retailers rather than in-store during the pandemic, while nearly 50% plan to stock up on supplies if it looks like there will be a shortage.
Clearly, the sector offers opportunity for smart companies to offer a comprehensive line of CBD-infused and topical products — and emerge as a trusted brand. Who better to rise to the challenge than an already recognized beverage leader that has clearly established its ability to deliver on consumer needs and market opportunities?
Meeting Rigorous Requirements
The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) has worked hard to build a national reputation as a well-respected beverage brand, and the transition to becoming a similar presence in the CBD space has been seamless. With already-established high standards in place, WTER guarantees that its A88CBD products are formulated in GFM facilities; use the highest-quality, lab-tested CBD from a trusted source; and follow rigorous quality control measures to establish consistency.
These rigorous requirements will become even more essential as CBD becomes more mainstream, attracting a new products and brands to the space. Major players are eager to to add quality CBD products to their offerings, but these distributors have strict requirements. Smaller cannabis producers and brands with limited resources may be unable to produce products that meet those demands, but The Alkaline Water Company is already doing so.
As a trusted brand, WTER and its leading A88CBD brand provide exactly what retailers are demanding: superior quality topicals, oils, capsules, tinctures and gummies.
Capturing Share in $20-Billion Market
The Alkaline Water Company is clearly committed to its best-in-class A88CBD line; the company just launched five category-leading items. “These products, which include our delicious lemon-lime CBD water, vegan gummies, zero-calorie powder packs, all-natural bath bombs and cruelty-free deep relief cream, complement our existing product lineup,” said WTER president and CEO Richard A. Wright. “Our robust product lineup effectively positions us to capture share in the estimated $20 billion-plus, hemp-derived consumer products market.”
Focused on capturing as much of the growing market as possible, WTER is committed to grow both its online and in-store presence. A88CBD products are currently available in approximately 400 retail locations, including Elevated Wellness CBD, CBD Emporium, Alchemist Kitchen, Pure CBD, and select Vitamin Plus locations. Online, A88CBD products can be found on WTER’s direct-to-consumer e-commerce site at www.A88CBD.com the products are also available at Amazon, CBD.co, healwithnature.com and DirectCBDOnline.com
Developing both a vibrant online presence and robust retail locations is a priority for WTER as it works to increasing sales in the CBD space. With that in mind, Wright explained that the company is planning to continue to grow its online presence through unique digital marketing strategies and leverage its existing brick-and-mortar footprint for its A88CBD portfolio of products.
“We are in active discussions with over 9,000 retail locations to take on our products over the coming 90 days,” he said during the Q2 financial webcast. “With an in-demand portfolio of offerings, a strong partner network, and an established retail base, we are taking aggressive actions to capture share in the large and growing retail trades we currently serve and greenfield opportunities in the CBD and hospitality and foodservice arena. Additionally, our e-commerce sites continue to exceed our expectations and provide another growth area driven by shifting consumer behaviors. We also expect the multi-year health and wellness trend to accelerate coming out of the COVID pandemic and anticipate our lifestyle brands to benefit due to our sales and marketing efforts made this year.”
A Strong Candidate Fills Unique Niche
WTER’s impressive A88CBD product line is only one piece of The Alkaline Water Company’s strategic business puzzle. The company’s flagship product, Alkaline88(R), is one of the strongest performers in the beverage world, and the company continues to report record sales. “Our family of brands — Alkaline88, A88 Infused and A88CBD Infused — include a growing portfolio of products that are in demand and resonate with consumers,” Wright said.
A recent “Proactive Investor” article observed that “well-financed suitors may well be interested in the Alkaline Water Company given its unique niche. After all, a Neilson report ranked Alkaline88 as ‘one of the fastest growing’ value-added waters in 2019. It also noted that the company has built a ‘national retail footprint’ and extended its lifestyle brands into other consumer packaged goods categories.”
WTER’s stability and commitment to quality, along with its distinctive variable-cost business model and strong portfolio, make the company a strong prospect for major players in the beverage or cannabis space that are may be looking to strengthen their position in these key sectors.
Evaluating the Opportunities
With a trillion-dollar industry projection as a backdrop, it’s no wonder that other companies besides WTER are also evaluating the opportunities.
Tilray Inc.’s (NASDAQ: TLRY) new High Park portfolio additions for Canada in 2020 include edibles, confectionery goods, CBD beverages and more, expanding High Park’s existing broad-based portfolio of brands and products. The additions feature new confectionery brand Chowie Wowie(TM), new wellness brand Rmdy(TM), and new beverage brand Everie, developed by Fluent. In addition, the line brings U.S. brands Marley Natural(TM) and Goodship(TM) to the Canadian market. High Park’s team of brand leaders and R&D experts have worked rigorously to deliver to consumers best-in-class cannabis products that meet the highest standards of safety and quality as required by Health Canada.
Anheuser-Busch InBev SA (NYSE: BUD) has announced a joint venture with Tilray to commercialize non-alcohol, CBD-infused beverages in Canada once regulations allow. The joint venture will operate under the Fluent Beverage Company. AB InBev is participating in the partnership through its subsidiary Labatt Breweries of Canada, one of the country’s founding businesses and its leading brewer. Tilray is participating through its Canadian adult-use cannabis subsidiary High Park Company.
Aphria Inc.’s (NASDAQ: APHA) (TSX: APHA) expansion of its 510 Vape offering strengthens the company’s commitment to inspire and empower the worldwide community to live its best life. Each Aphria vape is designed with a unique offering to meet the demands of a diverse consumer segment. “Since day one we have been committed to strategically developing an award-winning brand portfolio that resonates with Canadians, provides exceptional patient and consumer experiences, and competes against the illicit market,” said Aphria CEO Irwin D. Simon. “We believe the strength of our brands remain unmatched in the industry and are excited to expand 510 vapes across our brand portfolio, including Broken Coast’s first cannabis 2.0 product.”
Curaleaf Holdings Inc. (OTC: CURLF) (CSE: CURA) is continuing its Western expansion of Select brand products. With the launch of its gummies in California and cartridges in Nevada, Curaleaf now offers products in 12 states. “The latest product expansion of Select in California and Nevada speaks to Cureleaf’s commitment to providing both medical patients and adult-use customers with accessibility to innovative, high-quality cannabis products,” said Curaleaf president Joe Bayern. “We are thrilled to bring Select’s scientifically formulated Nano Gummies and Elite Live to both states as we expand our portfolio and provide entry points for new consumers.”
The wave of acceptance for cannabis, and specifically CBD, isn’t likely to ebb, as a growing number of consumers look for superior products that provide life-changing benefits. Companies leading the way in the space will only benefit as the trillion-dollar mark grows closer.
For more information about The Alkaline Water Company, please visit The Alkaline Water Company.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a research report by the Benchmark Company LLC. The report, titled “Processa Pharmaceuticals Inc. (PCSA) Processing Assets to the FDA; Initiate at Buy,” lists a $15 price target at initiation of coverage. The report reads, “We initiate PCSA with a Speculative Buy rating as we consider the two leading assets in PCSA’s pipeline portfolio as most promising and with potential value. Eniluracil probably can reduce adverse events and improve efficacy of 5-FU/capecitabine that are standard-of-care for multiple cancer indications. Another asset, deuterated pentoxifylline, may help patients with ulcerative necrobiosis lipoidica, a skin disorder with no FDA-approved agents, to heal the ulcers in an expedient way. While we keep our current PoS at 20%, as PCSA moves forward in clinical development the value of the company should grow accordingly, in our opinion.”
To view the full report, visit: https://ibn.fm/9GWkG
About Processa Pharmaceuticals Inc.
The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company used these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active pipeline programs include: PCS6422 (metastatic colorectal cancer and breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (GI motility/gastroparesis). The members of the Processa development team have been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at http://ibn.fm/PCSA
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
- Financial numbers show revenues stay level, gross margins up and operations expenses down.
- Company continues focus on primary mission of applying artificial intelligence to precision medicine, drug discovery.
- POAI subsidiaries all showing progress, growth in key areas.
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has released its Q3 2020 financial report along with an update of company accomplishments and achievements (https://ibn.fm/HCpQM). In the report, POAI CEO Dr. Carl Schwartz noted milestones for each of the company’s subsidiaries: Helomics, TumorGenesis, Soluble Biotech and Skyline Medical.
“Our operating cash improved over the first nine months of 2020 as a result of an improvement in operating expenses, if the non-cash expense for goodwill impairment is excluded, continued new sales of our STREAMWAY Systems, which provide an annuity-like revenue stream from ongoing sales of disposables, and proceeds from equity offerings, indicating investor confidence in our emerging precision medicine business,” said Schwartz. “Concurrently, we are taking the necessary steps to manage our balance sheet, including reducing our accounts payable and reducing our derivative liability by amending a settlement provision for certain outstanding warrants.
“Management continues to focus the majority of its resources on the company’s primary mission of applying artificial intelligence to precision medicine and to drug discovery,” Schwartz continued. “Our approach and the mediums used to replace rats and mice in preliminary cancer studies are working in three of our operating subsidiaries, Helomics, TumorGenesis and Soluble Biotech.”
In the report, Schwartz noted the following company milestones:
- Signed first contract with a pharmaceutical company for protein expression, solubility studies
- Completed asset purchase of Quantitative Medicine (“QM”), a biomedical analytics and computational biology company
- Sold 15 STREAMWAY(R) systems
In addition, POAI reported its Q3 revenues — $0.5 million — were level with the same quarter last year; revenues were primarily driven by sales of Predictive Oncology’s proprietary STREAMWAY product line. In addition, gross margin was 64% in the third quarter of 2020 compared with 60% in Q3 2019, general and administrative expenses declined 15% to $2.2 million in Q3 2020, and operations expenses slightly decreased in the same period due to lower costs related to staff, including share-based compensation.
Regarding each of POAI’s subsidiaries, Schwartz made the following comments:
- Helomics: “We are making steady progress in our Helomics division with the launch of a restructured clinical test offering to clinicians for ovarian cancer. Our project with UPMC-Magee Womens Hospital, analyzing the genomic and drug response profiles of women with ovarian cancer to build predictive models’ terms of therapy response, is close to completion. We are also in discussions with several pharmaceutical companies about partnerships that will monetize our efforts.”
- Soluble Biotech: “We signed our first contract with a pharmaceutical company for protein expression and solubility studies. Importantly, this win validates our investment in state-of-the-art lab equipment and expanded facilities. We are working judiciously to secure additional contracts with other biotechnology and pharmaceutical companies.”
- TumorGenesis: “We introduced our Ovarian Cell Line Media at the BIO-Europe Digital Conference where numerous researchers learned from us how they can isolate and successfully culture ovarian cancer cells that previously could not be cultured. Cornell University (Weill) Medical School and TumorGenesis are collaborating to help identify the best culture media for the studying of mutations that increase the risk of ovarian, breast and other types of cancers.”
- Skyline Medical: “[This] division continues to be self-sustaining, from an operating cash perspective, as sales of new waste fluid management systems and recurring sales of disposables to support those systems more than cover the operating expenses and capital needs of this segment of our business. Importantly, sustaining and even modestly growing this division provides us with cash we need as we accelerate the precision medicine components of our business.”
POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.
For more information, visit the company’s website at www.Predictive-Oncology.com
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Net Element (NASDAQ: NETE) is a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc. The merger is optimally timed as more and more regulations aim to require and encourage adoption of purely electric automobiles as a replacement to conventional combustion engine-powered cars. A recent article discussing the company’s positioning reads, “Net Element and Mullen Technologies have revealed plans to begin their foray into the U.S. electric vehicle market through their partnership with Chinese EVET manufacturer, Qiantu Motors, with the aim of marketing and selling the latter company’s vehicles in the U.S. The joint-venture’s first product will be the K50 Dragonfly — an all-electric, two-seat, carbon-fiber-bodied sports car that can go from 0-100 km/hr in 4.6 seconds (faster than a Porsche Boxster) and which is set to begin deliveries from 2Q2021 onwards.”
To view the full article, visit https://ibn.fm/C1kqJ
About Net Element Inc.
Net Element operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. On Aug. 5, 2020, Net Element announced the execution of a definitive agreement to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company in a stock-for-stock reverse merger in which Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger company (the “contemplated merger”). The contemplated merger is subject to customary closing conditions, regulatory approvals and shareholder approval for both companies. For additional information, visitwww.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.GreenCarStocks.com
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com
Green Car Stocks is part of the InvestorBrandNetwork.
- Net Element plans to radically transform its business model following completion of merger with Mullen Technologies, converting into pure-play EV manufacturer
- Electric vehicles are set to account for 3% of global vehicle sales in 2020
- Governments have increasingly pushed for electric vehicle adoption as key pillar underpinning environmental objectives; the UK just announced ban on sale of fossil-fuel powered cars by 2030
- NETE CEO Oleg Firer recently elaborated on challenges of entrepreneurship, role of diplomacy within modern corporate management
Net Element (NASDAQ: NETE) presents its stakeholders with a unique business proposition: Within its role as a global financial technology and value-added solutions group, Net Element provides its customers with electronic payments solutions spanning across point-of-sale, e-commerce and mobile devices, both in the United States and in selected emerging markets. It is under this very model that the company has seen its fortunes rise exponentially, with revenues climbing from $0 in 2013 to $65 million as of 2019.
Under the leadership of CEO Oleg Firer, a veteran entrepreneur and corporate turn-around specialist, Net Element has recently sought to radically transform its business model, with plans to jettison its long-standing payments business in favor of converting into a pure-play electric vehicle (“EV”) manufacturer (https://ibn.fm/kdqCv).
On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately held Mullen Technologies Inc., a Southern California-based electric vehicle company. The transaction, which will be in the form of a stock-for-stock reverse merger where Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company, will mark Net Element’s entry into one of the fastest-growing sectors within the global economy (https://ibn.fm/dYUea).
According to the International Energy Agency, sales of electric vehicles topped 2.1 million units globally in 2019, boosting the global stock to 7.2 million electric vehicles. The sector has evidenced a precipitous surge in growth, with electric vehicles – which accounted for 2.6% of global car sales and about 1% of the global automotive stock in 2020—registering a 40% year-on-year increase in sales last year; meanwhile, electric vehicles sales are anticipated to continue growing relative to those of their internal combustion engine-powered peers, accounting for approximately 3% of global car sales in 2020.
In addition to their growing popularity among automobile purchasers, electric vehicles have gained in prominence given that they represent a key technology to be used in high-profile global initiatives: the reduction of air pollution in densely populated areas and in the assistance of achieving greenhouse gas emissions reduction objectives. To date, 17 countries have announced 100% zero-emission vehicle targets, with the UK recently announcing a domestic ban on the sale of fossil fuel-powered vehicles by 2030 (https://ibn.fm/Ne5dU).
While Net Element’s segue into the electric vehicles space demonstrates remarkable foresight given the growth prospects attributed to the sector, it does not come without its own inherent challenges – ensuring corporate management ‘buy-in’ may be just as critical as a sector’s long-term potential, according to CEO Oleg Firer.
“Being a chief executive in business is very similar to being a diplomat,” Firer noted. “Managing a business in today’s environment requires constant negotiations at the executive levels and diplomatic approach to mid-management. One of my favorite diplomatic approaches to management is an ability to promote and seed an idea or a solution within, where your colleagues begin to believe in it as much as they begin present and solicit this idea or solutions rest of the group.”
Given Firer’s stellar track-record at the helm of various companies – which has included being awarded Inc Magazine’s prize as the United States’ fastest growing private sector company in 2012, the future looks bright for Net Element as it prepares to take on new challenges amidst the company’s planned foray into the world of electric vehicles.
For more information, visit the company’s website at www.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.GreenCarStocks.com
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com
Green Car Stocks is part of the InvestorBrandNetwork.
iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, and its board of directors has announced a share repurchase program. The program allows ICLK to purchase its own ADSs with an aggregate value of up to $15 million during the period of Dec. 30, 2020, to Dec. 31, 2021. The company intends to fund the repurchase using existing cash balance funds, which include monies generated from operations. iClick expects to effect the proposed program in three ways: on the open market at prevailing market prices, in negotiated transactions off the market, and in other permissible ways that are in compliance with applicable requirements. The announcement notes that the company is not obligated to acquire any particular number of ADSs; the share repurchase program may also be suspended, terminated or extended at any time. “This share repurchase program demonstrates our continued confidence in our long-term business growth and successful transformation towards an Integrated Enterprise and Marketing Cloud Platform,” said iClick co-founder and CEO Jian “T.J.” Tang in the press release. “We are committed to creating shareholder value, and believe that our business strategy and execution ability will continue to drive the long-term growth of the firm.”
To view the full press release, visit http://ibn.fm/F94q9
About iClick Interactive Asia Group Limited
iClick Interactive is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, the company’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in 10 locations worldwide including Asia and Europe. For more information about the company, please visit www.iClick.com.<
NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
With more companies and countries going green, the demand for some metals and other renewable energies is bound to increase. This makes mining an important feature in a low-carbon future. Some of the minerals whose demand may grow include rare earth elements, cobalt and nickel.
The executive director of Mining Industry ML Ed Moriarity explains that the demand for both cobalt and nickel is expected to increase by more than 1,000% by the year 2050. Both cobalt and nickel are used in batteries of electric vehicles.
The battery industry is also forecasted to grow in the next decade to $90 billion from $23 billion. This increase will mainly be caused by the growth in adoption of electric vehicles (EVs). The UK is also planning to ban the sale of diesel and petrol cars by the year 2030, which will help further boost the industry.
Tesla founder Elon Musk recently announced to investors that the company was willing to award a huge contract to any firm that could mine nickel in a way that was both environmentally sensitive and efficient. He added that the contract would last for a long time, as Tesla needs a mining company that can meet the EV firm’s demands, which are expected to increase as more people shift to electric vehicles.
This may be good news for Vale, the operator of Voisey’s Bay, which has what we may call ethical nickel deposits. In 2018, Vale announced that it would be extending its Labrador mine’s life, moving its operations further underground. While the pandemic may have interfered with the company’s plans, Vale did announce recently that the two underground mines are 55% complete. One of the mines is set to begin production in summer 2022 and another in spring 2021.
Once this expansion is complete, the operational costs of the mine will double, and its capital costs will become four times as much. However, to discover new mining sites that hold deposits of the minerals, mineral mapping needs to be conducted. This may take some time, as there’s a lot that goes into exploration work. Voisey’s Bay, for example, was discovered in 1993 but didn’t begin production until almost 12 years later.
Despite not being in commercial production at the moment, Southern Labrador and its rare earth element deposits, which has metals such as cobalt and nickel, is going to be in high demand as vehicle electrification grows. These metals are used in various gadgets, including smartphones, computers and TV screens.
The United States also has its fair share of mining firms excelling at what they do. An example is Energy Fuels Inc. (TSX: EFR) (NYSE American: UUUU). The company’s success at extracting vanadium and uranium has allowed it to branch out into the production of rare earth elements.
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.MiningNewsWire.com
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com
MiningNewsWire is part of the InvestorBrandNetwork.
LAKEWOOD, Colo. , Dec. 10, 2020 – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (“Energy Fuels” or the “Company”) , a leading producer of critical minerals in the United States , is pleased to announce that the Company’s President and CEO Mark S. Chalmers will be presenting live at the 13 th Annual LD Micro Main Event investor conference on Monday, December 14, 2020 at 11:40 AM (EST) .
Mr. Chalmers will provide an update on Energy Fuels’ various critical mineral initiatives, with particular emphasis on the Company’s progress on rare earth elements.
Register Here: ve.mysequire.com/
The Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts.
“The time has finally come to do something different in the virtual conference world. Let’s see if we can pull off something that can be enjoyed by both executives and investors alike,” stated Chris Lahiji , Funder of LD, now a wholly owned subsidiary of SRAX, Inc.
The Main Event will take place on December 14 th and 15 th , exclusively on the Sequire Virtual Events platform.
View Energy Fuels’ profile here: http://www.ldmicro.com/profile/uuuu
Profiles powered by LD Micro
About Energy Fuels : Energy Fuels is the leading U.S.-based uranium mining company, supplying U 3 O 8 to major nuclear utilities. The Company also produces vanadium from certain of its projects, as market conditions warrant, and it is evaluating the potential to produce rare earth elements. Its corporate offices are near Denver, Colorado , and all of its assets and employees are in the United States . Energy Fuels holds three of America’s key uranium production centers – the White Mesa Mill in Utah , the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming , and the Alta Mesa ISR Project in Texas . The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U 3 O 8 per year, and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U 3 O 8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U 3 O 8 per year. In addition to the above production facilities, Energy Fuels has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the Company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” Energy Fuels’ website is www.energyfuels.com .
About LD Micro/SEQUIRE : LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. For more information, please visit ldmicro.com . The upcoming Main Event will be highlighting a new format that will benefit both executives and the investors tuning in from all over the globe. In September 2020 , LD Micro. Inc. was acquired by SRAX, Inc., a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire , companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com .
Cautionary Note Regarding Forward-Looking Statements: This news release contains certain “Forward-Looking Information” and “Forward-Looking Statements” within the meaning of applicable United States and Canadian securities legislation, which may include, but are not limited to, statements with respect to any expectations regarding: uranium production, uranium and vanadium inventories and progress on rare earth elements . Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “plans,” “expects,” “does not expect,” “is expected,” “is likely,” “budgets,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates,” “does not anticipate,” or “believes,” or variations of such words and phrases, or state that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “occur,” “be achieved” or “have the potential to.” All statements herein, other than statements of historical fact, are considered to be forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance of or achievements of the Company to be materially different from any future results, performance, or achievements, express or implied, by the forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements include risks associated with: any expectations regarding uranium production, uranium and vanadium inventories and progress on rare earth elements; and the other factors described under the caption “Risk Factors” in the Company’s most recently filed Annual Report on Form 10-K, which is available for review on EDGAR at www.sec.gov/edgar.shtml , on SEDAR at www.sedar.com , and on the Company’s website at www.energyfuels.com . Forward-looking statements contained herein are made as of the date of this news release, and the Company disclaims, other than as required by law, any obligation to update any forward-looking statements whether as a result of new information, results, future events, circumstances, or as a result of changes in management’s estimates or opinions, or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements. The Company assumes no obligation to update the information in this communication, except as otherwise required by law.
The mental health treatments being used around the world sometimes seem to be doing more harm than good to their consumers, with patients often becoming either addicted to their treatments or treatment resistant. Atai Life Sciences cofounder Florian Brand states that only 50% of individuals respond to selective serotonin reuptake inhibitors, which is the most common depression and anxiety treatment. In addition, this approach can take up to three months for an individual to notice any changes in their symptoms, and individuals have a 33% probability of their bodies resisting the treatment.
Backed by its founders, Atai Life Sciences believes that psychedelics may help. Currently, the firm is developing mental health treatment drugs that include psilocybin, MDMA and ketamine. The company, which was launched in 2018, announced last month that it had raised $125 million in new funding from investors such as Peter Thiel, PayPal founder and Facebook investor.
Brand explains that the company’s aim is to fast track mental health innovation in a responsible way. He adds that his interest in the psychedelic treatments stem from personal mental health experiences. He explains that he suffered from severe anxiety and was treated with psychotherapy but adds that, while it may have worked for him, many others do not respond to the treatment options available.
The firm owns 10 other companies that each work on a different compound designed to help treat mental health conditions. Compass Pathways, one of the companies operating on this decentralized strategy for drug development, is developing a psilocybin treatment. This psychedelic substance is effective in unlocking an individual’s trauma that resulted in a mental health issue, thus allowing the cause to be explored further in therapy.
Another company is working on a drug that is akin to esketamine, which is currently used to manage depression. The drug is arketamine, which can be given at home as it gives rise to less of a hallucinogenic effect.
One of the company’s other firms is working with ibogaine, which has the potential to be used in the treatment of an addiction to opioid. The psychoactive compound occurs naturally in the root bark of Tabernanthe iboga, an African shrub.
Brand also explains that Atai is focused on developing drugs that are tailored to treat mental health conditions differently in different individuals. The company is currently developing tracking biomarkers, which will help indicate the type of help that a patient requires.
Additionally, the company is working on making its drugs more affordable. The reason behind this is because a majority of people with depression cannot afford treatments that are out of pocket.
Atai isn’t the only company in the psychedelics sector though. Other players are also taking bold steps in this industry. For example, Cybin Inc. (NEO: CYBN) is hard at work developing pharmaceutical products from psychedelic substances, and the company also has an interest in the functional mushroom segment.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
